Alvotech has developed a biosimilar of Humira called AVT02, the first-filed biosimilar drug equal in strength to Humira’s latest formulation, which AbbVie markets as a high-concentration, pain ...

A real-world study reveals that pediatric patients with IBD achieve high remission rates and cost savings using adalimumab ...